Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Wynn Resorts
WYNN
$10.3B
| $82.1M | 0.04% |
646,072
-104,809
| -14% | -$15.6M |
|
452
Nasdaq
NDAQ
$52.5B
| $81.7M | 0.04% |
2,858,265
+1,021,251
| +56% | +$31.4M |
|
453
TransDigm Group
TDG
$71.7B
| $81.7M | 0.04% |
219,446
+128,082
| +140% | +$46.1M |
|
|
TFCF
454
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $81.6M | 0.04% |
1,781,595
+1,212,472
| +213% | +$55M |
|
|
LEXEA
455
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $81.3M | 0.04% |
1,727,762
-314,574
| -15% | -$14.7M |
|
456
Helmerich & Payne
HP
$3.37B
| $81.1M | 0.04% |
1,179,228
+491,300
| +71% | +$31.4M |
|
457
Seagate
STX
$182B
| $80.8M | 0.04% |
1,706,099
+1,267,870
| +289% | +$67.8M |
|
458
Axalta
AXTA
$7.23B
| $80.5M | 0.04% |
2,759,610
+102,026
| +4% | +$3.06M |
|
459
Universal Health Services
UHS
$9.77B
| $79.9M | 0.04% |
624,768
+1,426
| +0.2% | +$175K |
|
|
XLRN
460
DELISTED
Acceleron Pharma
XLRN
| $79.8M | 0.04% |
1,394,256
+161,049
| +13% | +$7.91M |
|
461
World Kinect Corp
WKC
$2.03B
| $78.8M | 0.04% |
2,845,802
-28,355
| -1% | -$728K |
|
462
State Street SPDR S&P 500 ETF Trust
SPY
$780B
| $78.7M | 0.04% |
270,665
+12,155
| +5% | +$3.46M |
|
463
Globus Medical
GMED
$10.6B
| $78.1M | 0.04% |
1,375,151
-25,799
| -2% | -$1.36M |
|
464
GATX Corp
GATX
$6.45B
| $77.1M | 0.04% |
889,854
+40,142
| +5% | +$3.33M |
|
465
Public Service Enterprise Group
PEG
$39.4B
| $76.6M | 0.04% |
1,451,548
+548,622
| +61% | +$28.7M |
|
|
ONC
466
BeOne Medicines Ltd
ONC
$33.9B
| $76.2M | 0.04% |
442,507
+54,593
| +14% | +$9.18M |
|
467
Merit Medical Systems
MMSI
$4.57B
| $75.9M | 0.04% |
1,235,626
-3,858
| -0.3% | -$222K |
|
468
Wave Life Sciences
WVE
$1.14B
| $75.8M | 0.04% |
1,516,780
-1,978
| -0.1% | -$89.2K |
|
|
IMMU
469
DELISTED
Immunomedics Inc
IMMU
| $75.8M | 0.04% |
3,640,299
+422,540
| +13% | +$10M |
|
470
Conagra Brands
CAG
$7.3B
| $75.1M | 0.04% |
2,210,777
-953,203
| -30% | -$34.8M |
|
471
LendingTree
TREE
$561M
| $74.7M | 0.04% |
324,856
+41,948
| +15% | +$9.97M |
|
472
Ryder
R
$10.2B
| $74.7M | 0.04% |
1,022,619
+705,115
| +222% | +$53.7M |
|
|
GRUB
473
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $74.4M | 0.04% |
268,388
+3,079
| +1% | +$794K |
|
474
Ameren
AEE
$31.1B
| $74.2M | 0.04% |
1,172,979
-335,349
| -22% | -$21.1M |
|
475
Macy's
M
$6.56B
| $74.2M | 0.04% |
2,135,151
+1,940,793
| +999% | +$72.2M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.